1. Home
  2. IRWD
  3. IRWD News

Latest Ironwood Pharmaceuticals Inc. (IRWD) News on February 23, 2025

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call
IRWD

Business Wire

2 days ago

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call

Millrose Properties Set to Join S&P SmallCap 600
IRWD

PR Newswire

17 days ago

Millrose Properties Set to Join S&P SmallCap 600

IRWD

Argus Research

18 days ago

IRWD: Lowering target price to $2.00

IRWD

MT Newswires

24 days ago

Top Midday Decliners

IRWD Begins Apraglutide NDA Submission, Announces Job Cuts, Stock Falls
IRWD

Zacks

24 days ago

IRWD Begins Apraglutide NDA Submission, Announces Job Cuts, Stock Falls

IRWD

MT Newswires

24 days ago

Ironwood Pharmaceuticals to Slash Half of Workforce, Drop Phase 2 Testing of Drug; Issues 2025 Outlook

IRWD

Business Wire

24 days ago

Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future

IRWD

Argus Research

25 days ago

IRWD: What does Argus have to say about IRWD?

Calculating The Fair Value Of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)
IRWD

Simply Wall St.

a month ago

Calculating The Fair Value Of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

IRWD

Argus Research

a month ago

IRWD: What does Argus have to say about IRWD?

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
IRWD

TipRanks

a month ago

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

IRWD

Argus Research

a month ago

IRWD: Lowering target price to $3.00

IRWD

Argus Research

2 months ago

IRWD: Raising target price to $4.00

Here’s Why Brown Capital Management Small Company Fund Sold Ironwood Pharmaceuticals (IRWD)
IRWD

Insider Monkey

2 months ago

Here’s Why Brown Capital Management Small Company Fund Sold Ironwood Pharmaceuticals (IRWD)

IRWD

Argus Research

2 months ago

IRWD: What does Argus have to say about IRWD?

IRWD

Argus Research

2 months ago

IRWD: What does Argus have to say about IRWD?

High Growth Tech Stocks In The United States To Watch
IRWD

Simply Wall St.

2 months ago

High Growth Tech Stocks In The United States To Watch

IRWD

Argus Research

3 months ago

IRWD: What does Argus have to say about IRWD?

Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference
IRWD

Business Wire

3 months ago

Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference

Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference
IRWD

Business Wire

3 months ago

Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference

IRWD

Argus Research

3 months ago

IRWD: What does Argus have to say about IRWD?

Ironwood's Q3 Earnings Lag Estimates, Revenues Top, Stock Down
IRWD

Zacks

3 months ago

Ironwood's Q3 Earnings Lag Estimates, Revenues Top, Stock Down

Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ...
IRWD

GuruFocus.com

3 months ago

Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ...

Ironwood Pharmaceuticals (IRWD) Misses Q3 Earnings Estimates
IRWD

Zacks

4 months ago

Ironwood Pharmaceuticals (IRWD) Misses Q3 Earnings Estimates

IRWD

Associated Press Finance

4 months ago

Ironwood: Q3 Earnings Snapshot

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results
IRWD

Business Wire

4 months ago

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results

Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Report Preview: What To Expect
IRWD

GuruFocus.com

4 months ago

Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Report Preview: What To Expect

IRWD

Argus Research

4 months ago

IRWD: Raising target price to $4.00

IRWD

MT Newswires

4 months ago

Ironwood Says Apraglutide Shows 'Consistent Treatment Effect' in Short Bowel Syndrome; Shares Rise

Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024
IRWD

Business Wire

4 months ago

Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024

Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call
IRWD

Business Wire

4 months ago

Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call

State Street Corp's Strategic Acquisition of Ironwood Pharmaceuticals Shares
IRWD

GuruFocus.com

4 months ago

State Street Corp's Strategic Acquisition of Ironwood Pharmaceuticals Shares

Is Ironwood Pharmaceuticals, Inc. (IRWD) the Penny Stock with the Biggest Upside Potential According to Analysts?
IRWD

Insider Monkey

4 months ago

Is Ironwood Pharmaceuticals, Inc. (IRWD) the Penny Stock with the Biggest Upside Potential According to Analysts?

Ironwood Pharmaceuticals Inc (IRWD) Q2 2024 Earnings Call Highlights: Strong LINZESS Demand ...
IRWD

GuruFocus.com

4 months ago

Ironwood Pharmaceuticals Inc (IRWD) Q2 2024 Earnings Call Highlights: Strong LINZESS Demand ...

IRWD

Argus Research

4 months ago

IRWD: What does Argus have to say about IRWD?

Implied Volatility Surging for Ironwood (IRWD) Stock Options
IRWD

Zacks

5 months ago

Implied Volatility Surging for Ironwood (IRWD) Stock Options

IRWD

MT Newswires

5 months ago

Leerink Partners Initiates Coverage on Ironwood Pharmaceuticals With Market Perform Rating, $5 Price Target

Ironwood Pharmaceuticals, Inc. (IRWD): The Best Multibagger Penny Stock of 2025?
IRWD

Insider Monkey

6 months ago

Ironwood Pharmaceuticals, Inc. (IRWD): The Best Multibagger Penny Stock of 2025?

Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference
IRWD

Business Wire

6 months ago

Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference

IRWD

Argus Research

6 months ago

IRWD: What does Argus have to say about IRWD?

IRWD

Argus Research

6 months ago

IRWD: Raising target price to $4.00

Analysts Have Just Cut Their Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Revenue Estimates By 13%
IRWD

Simply Wall St.

6 months ago

Analysts Have Just Cut Their Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Revenue Estimates By 13%

Ironwood Pharmaceuticals, Inc. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts
IRWD

Simply Wall St.

6 months ago

Ironwood Pharmaceuticals, Inc. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts

Ironwood (IRWD) Q2 Earnings & Revenues Fall Shy of Estimates
IRWD

Zacks

6 months ago

Ironwood (IRWD) Q2 Earnings & Revenues Fall Shy of Estimates

Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q2
IRWD

Zacks

6 months ago

Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q2

IRWD

Associated Press Finance

6 months ago

Ironwood: Q2 Earnings Snapshot

Ironwood Pharmaceuticals Reports Second Quarter 2024 Results
IRWD

Business Wire

6 months ago

Ironwood Pharmaceuticals Reports Second Quarter 2024 Results

Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q2 Earnings Expected to Decline
IRWD

Zacks

7 months ago

Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q2 Earnings Expected to Decline

Ironwood Pharmaceuticals (NASDAQ:IRWD) shareholders have endured a 49% loss from investing in the stock three years ago
IRWD

Simply Wall St.

7 months ago

Ironwood Pharmaceuticals (NASDAQ:IRWD) shareholders have endured a 49% loss from investing in the stock three years ago

Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call
IRWD

Business Wire

7 months ago

Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call

IRWD

Argus Research

7 months ago

IRWD: Lowering target price to $5.00

Implied Volatility Surging for Ironwood Pharmaceuticals (IRWD) Stock Options
IRWD

Zacks

7 months ago

Implied Volatility Surging for Ironwood Pharmaceuticals (IRWD) Stock Options

IRWD

Argus Research

7 months ago

IRWD: Raising target price to $6.00

IRWD

Argus Research

7 months ago

IRWD: What does Argus have to say about IRWD?

IRWD

Argus Research

8 months ago

IRWD: Lowering target price to $5.00

IRWD

MT Newswires

8 months ago

Ironwood Pharmaceuticals Names Sravan Emany to Additional Role of Chief Operating Officer

Insider Sale: Director Julie Mchugh Sells Shares of Ironwood Pharmaceuticals Inc (IRWD)
IRWD

GuruFocus.com

8 months ago

Insider Sale: Director Julie Mchugh Sells Shares of Ironwood Pharmaceuticals Inc (IRWD)

Insider Sale: Director Catherine Moukheibir Sells 80,000 Shares of Ironwood Pharmaceuticals Inc ...
IRWD

GuruFocus.com

8 months ago

Insider Sale: Director Catherine Moukheibir Sells 80,000 Shares of Ironwood Pharmaceuticals Inc ...

IRWD

MT Newswires

8 months ago

Ironwood Pharmaceuticals Insider Sold Shares Worth $517,694, According to a Recent SEC Filing

Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
IRWD

Business Wire

9 months ago

Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

IRWD

MT Newswires

9 months ago

Ironwood Pharmaceuticals Insider Sold Shares Worth $436,136, According to a Recent SEC Filing

Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
IRWD

Business Wire

9 months ago

Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)

US$16.33: That's What Analysts Think Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Is Worth After Its Latest Results
IRWD

Simply Wall St.

9 months ago

US$16.33: That's What Analysts Think Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Is Worth After Its Latest Results

IRWD

GuruFocus.com

9 months ago

Ironwood Pharmaceuticals Reports Mixed Q1 2024 Results Amid Key Clinical Advancements

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript
IRWD

Insider Monkey

9 months ago

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript

Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates
IRWD

Zacks

9 months ago

Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates

Ironwood Pharmaceuticals First Quarter 2024 Earnings: US$0.03 loss per share (vs US$0.30 profit in 1Q 2023)
IRWD

Simply Wall St.

9 months ago

Ironwood Pharmaceuticals First Quarter 2024 Earnings: US$0.03 loss per share (vs US$0.30 profit in 1Q 2023)

IRWD

MT Newswires

9 months ago

Sector Update: Health Care Stocks Higher Late Afternoon

IRWD

MT Newswires

9 months ago

Sector Update: Health Care Stocks Gain in Thursday Afternoon Trading

IRWD

MT Newswires

9 months ago

Sector Update: Health Care

IRWD

MT Newswires

9 months ago

Ironwood Pharmaceuticals' Shares Fall After Q1 Swings to a Non-GAAP Loss, Revenue Declines; 2024 Revenue Guidance Cut

IRWD

Associated Press Finance

9 months ago

Ironwood: Q1 Earnings Snapshot

Ironwood Pharmaceuticals Reports First Quarter 2024 Results
IRWD

Business Wire

9 months ago

Ironwood Pharmaceuticals Reports First Quarter 2024 Results

Ironwood Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference
IRWD

Business Wire

10 months ago

Ironwood Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference

Stonegate Healthcare Partners Updates Report on Transformative Therapies for Pruritus Management
IRWD

Newsfile

10 months ago

Stonegate Healthcare Partners Updates Report on Transformative Therapies for Pruritus Management

Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q1 Earnings Expected to Decline
IRWD

Zacks

10 months ago

Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q1 Earnings Expected to Decline

Ironwood Pharmaceuticals to Present New Data on Once-Weekly Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) at Digestive Disease Week® 2024
IRWD

Business Wire

10 months ago

Ironwood Pharmaceuticals to Present New Data on Once-Weekly Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) at Digestive Disease Week® 2024

Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call
IRWD

Business Wire

10 months ago

Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call

IRWD

Argus Research

10 months ago

IRWD: Raising target price to $9.00

Ironwood Pharmaceuticals Announces Positive Results from its Phase II Exploratory STARGAZE Trial of Apraglutide in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease (SR GI aGVHD)
IRWD

Business Wire

a year ago

Ironwood Pharmaceuticals Announces Positive Results from its Phase II Exploratory STARGAZE Trial of Apraglutide in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease (SR GI aGVHD)

OPKO Health (OPK) And Entera Bio Announce Data for GLP-2
IRWD

Zacks

a year ago

OPKO Health (OPK) And Entera Bio Announce Data for GLP-2

It’s Time! 3 Failing Biotech Stocks to Sell Right Now
IRWD

InvestorPlace

a year ago

It’s Time! 3 Failing Biotech Stocks to Sell Right Now

Ironwood Pharmaceuticals Ran Up 38% Over Three Months — And Just Lost It All
IRWD

Investor's Business Daily

a year ago

Ironwood Pharmaceuticals Ran Up 38% Over Three Months — And Just Lost It All

IRWD

Reuters

a year ago

UPDATE 1-Ironwood's bowel disease treatment meets main goal in late-stage trial

IRWD

Reuters

a year ago

Ironwood says bowel disease treatment meets main goal in late-stage trial

Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
IRWD

Business Wire

a year ago

Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)

Ironwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference
IRWD

Business Wire

a year ago

Ironwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference

Ironwood Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectations
IRWD

Simply Wall St.

a year ago

Ironwood Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectations

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2023 Earnings Call Transcript
IRWD

Insider Monkey

a year ago

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2023 Earnings Call Transcript

Ironwood (IRWD) Q4 Earnings Miss, Revenues Beat Marginally
IRWD

Zacks

a year ago

Ironwood (IRWD) Q4 Earnings Miss, Revenues Beat Marginally

IRWD

Thomson Reuters StreetEvents

a year ago

Q4 2023 Ironwood Pharmaceuticals Inc Earnings Call

Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q4
IRWD

Zacks

a year ago

Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q4

IRWD

Associated Press Finance

a year ago

Ironwood: Q4 Earnings Snapshot

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance
IRWD

Business Wire

a year ago

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance

Ironwood (IRWD) is on the Move, Here's Why the Trend Could be Sustainable
IRWD

Zacks

a year ago

Ironwood (IRWD) is on the Move, Here's Why the Trend Could be Sustainable

IRWD

Business Wire

a year ago

Patterson Companies Elects Pamela Tomczik to Board of Directors

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Investor Update Call
IRWD

Business Wire

a year ago

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Investor Update Call

CG Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
IRWD

Business Wire

a year ago

CG Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Vista Oil & Gas, S.A.B. de C.V. Sponsored ADR (VIST) Stock Drops Despite Market Gains: Important Facts to Note
IRWD

Zacks

a year ago

Vista Oil & Gas, S.A.B. de C.V. Sponsored ADR (VIST) Stock Drops Despite Market Gains: Important Facts to Note

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30
IRWD

CNW Group

a year ago

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30

Share on Social Networks: